Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).

Kiefer EM, Shi Q, Hoover DR, Kaplan R, Tracy R, Augenbraun M, Liu C, Nowicki M, Tien PC, Cohen M, Golub ET, Anastos K.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):301-10. doi: 10.1097/QAI.0b013e31827fdd61.

2.

Association of markers of hemostasis with death in HIV-infected women.

Kiefer E, Hoover DR, Shi Q, Kuniholm MH, Augenbraun M, Cohen MH, Golub ET, Kaplan RC, Liu C, Nowicki M, Tien PC, Tracy RP, Anastos K.

J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):287-94. doi: 10.1097/QAI.0000000000000306.

3.

Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.

Kaplan RC, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Parrinello CM, Benning L, Tracy RP.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):359-68. doi: 10.1097/QAI.0b013e31825b03be.

4.

Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.

Reingold J, Wanke C, Kotler D, Lewis C, Tracy R, Heymsfield S, Tien P, Bacchetti P, Scherzer R, Grunfeld C, Shlipak M.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):142-8. doi: 10.1097/QAI.0b013e3181685727.

5.

Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection.

Shaked I, Hanna DB, Glei├čner C, Marsh B, Plants J, Tracy D, Anastos K, Cohen M, Golub ET, Karim R, Lazar J, Prasad V, Tien PC, Young MA, Landay AL, Kaplan RC, Ley K.

Arterioscler Thromb Vasc Biol. 2014 May;34(5):1085-92. doi: 10.1161/ATVBAHA.113.303153. Epub 2014 Mar 20.

6.

Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care.

Freiman JM, Huang W, White LF, Geng EH, Hurt CB, Taylor LE, Overton ET, Cachay ER, Kitahata MM, Moore RD, Rodriguez B, Mayer KH, Linas BP.

Clin Infect Dis. 2014 Dec 15;59(12):1686-93. doi: 10.1093/cid/ciu698. Epub 2014 Sep 3.

7.

Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.

Operskalski EA, Mack WJ, Strickler HD, French AL, Augenbraun M, Tien PC, Villacres MC, Spencer LY, Degiacomo M, Kovacs A.

J Clin Virol. 2008 Apr;41(4):255-63. doi: 10.1016/j.jcv.2007.08.021. Epub 2008 Feb 20.

8.

Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.

Bailony MR, Scherzer R, Huhn G, Plankey MW, Peters MG, Tien PC.

J Infect Dis. 2013 Dec 1;208(11):1776-83. doi: 10.1093/infdis/jit357. Epub 2013 Jul 30.

9.

Factors associated with D-dimer levels in HIV-infected individuals.

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD; INSIGHT SMART Study Group; ESPRIT Study Group; SILCAAT Scientific Committee.

PLoS One. 2014 Mar 13;9(3):e90978. doi: 10.1371/journal.pone.0090978. eCollection 2014.

10.

The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study.

Howard AA, Hoover DR, Anastos K, Wu X, Shi Q, Strickler HD, Cole SR, Cohen MH, Kovacs A, Augenbraun M, Latham PS, Tien PC.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):152-9. doi: 10.1097/QAI.0b013e3181d0c911.

11.

Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.

Sarkar M, Bacchetti P, Tien P, Mileti E, French AL, Edlin BR, Keller M, Seaberg E, Nowicki MJ, Young M, Peters MG.

Dig Dis Sci. 2013 May;58(5):1341-8. doi: 10.1007/s10620-012-2486-8. Epub 2012 Nov 24.

12.

Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study.

Crystal H, Kleyman I, Anastos K, Lazar J, Cohen M, Liu C, Pearce L, Golub E, Valcour V, Ho A, Strickler H, Peters M, Kovacs A, Holman S, Kreek MJ, Manly J.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):149-54. doi: 10.1097/QAI.0b013e318240566b.

13.
14.

Nonvalvular atrial fibrillation: evidence for a prothrombotic state.

Kahn SR, Solymoss S, Flegel KM.

CMAJ. 1997 Sep 15;157(6):673-81.

15.

Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women.

Reiner AP, Aragaki AK, Gray SL, Wactawski-Wende J, Cauley JA, Cochrane BB, Kooperberg CL, Woods NF, LaCroix AZ.

Am J Med. 2009 Oct;122(10):947-54. doi: 10.1016/j.amjmed.2009.04.016. Epub 2009 Aug 13.

16.

Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.

Armah KA, Quinn EK, Cheng DM, Tracy RP, Baker JV, Samet JH, Freiberg MS.

BMC Infect Dis. 2013 Aug 29;13:399. doi: 10.1186/1471-2334-13-399.

17.

Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.

Kovacs A, Karim R, Mack WJ, Xu J, Chen Z, Operskalski E, Frederick T, Landay A, Voris J, Spencer LS, Young MA, Tien PC, Augenbraun M, Strickler HD, Al-Harthi L.

J Infect Dis. 2010 Mar 15;201(6):823-34. doi: 10.1086/650997.

18.

Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.

Kushner LE, Wendelboe AM, Lazzeroni LC, Chary A, Winters MA, Osinusi A, Kottilil S, Polis MA, Holodniy M.

PLoS One. 2013 Apr 4;8(4):e60387. doi: 10.1371/journal.pone.0060387. Print 2013.

19.

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P.

Ann Hepatol. 2008 Apr-Jun;7(2):152-6.

PMID:
18626434
20.

Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.

Abera B, Zenebe Y, Mulu W, Kibret M, Kahsu G.

BMC Res Notes. 2014 Nov 25;7:838. doi: 10.1186/1756-0500-7-838.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk